Literature DB >> 10629355

Use of estrogens for the prevention and treatment of Alzheimer's disease.

D Monk1, H Brodaty.   

Abstract

This review examines the biological rationale for the use of estrogen replacement therapy (ERT) and the evidence for the efficacy of ERT in enhancing cognition, preventing Alzheimer's disease (AD) and treating AD in postmenopausal women. While the biological basis for ERT as a cognition enhancer is strong and multiply mediated, the clinical evidence for its use is not as compelling and must be weighed against possible side effects. Until the results of definitive large trials are available, the use of ERT alone or in combination with other treatments is worthy of consideration. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh：

Year:  2000        PMID： 10629355     DOI： 10.1159/000017206

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN： 1420-8008            Impact factor:   2.959


  9 in total

Review 1.  Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis.

Authors:  Walter A Rocca; Brandon R Grossardt; Lynne T Shuster
Journal:  Neurodegener Dis       Date:  2010-03-03       Impact factor: 2.977

2.  Reproductive History and Cognitive Aging: The Bogalusa Heart Study.

Authors:  Emily W Harville; Jack Guralnik; Maryellen Romero; Lydia A Bazzano
Journal:  Am J Geriatr Psychiatry       Date:  2019-07-05       Impact factor: 4.105

Review 3.  Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.

Authors:  Walter A Rocca; Brandon R Grossardt; Lynne T Shuster
Journal:  Brain Res       Date:  2010-10-18       Impact factor: 3.252

Review 4.  Combination therapy in Alzheimer's disease: a review of current evidence.

Authors:  Beate Schmitt; Tanja Bernhardt; Hans-Juergen Moeller; Isabella Heuser; Lutz Frölich
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Dietary Supplementation With Tinospora cordifolia Improves Anxiety-Type Behavior and Cognitive Impairments in Middle-Aged Acyclic Female Rats.

Authors:  Anmol Bhandari; Aditya Sunkaria; Gurcharan Kaur
Journal:  Front Aging Neurosci       Date:  2022-07-28       Impact factor: 5.702

7.  Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease.

Authors:  Antonin Bukovsky; Korakod Indrapichate; Hiroshi Fujiwara; Maria Cekanova; Maria E Ayala; Roberto Dominguez; Michael R Caudle; Jay Wimalsena; Robert F Elder; Pleas Copas; James S Foster; Romaine I Fernando; Donald C Henley; Nirmala B Upadhyaya
Journal:  Reprod Biol Endocrinol       Date:  2003-06-03       Impact factor: 5.211

Review 8.  Neurological health and premature ovarian insufficiency - pathogenesis and clinical management.

Authors:  Radosław Słopień
Journal:  Prz Menopauzalny       Date:  2018-09-30

9.  Link Between Dietary Sodium Intake, Cognitive Function, and Dementia Risk in Middle-Aged and Older Adults: A Systematic Review.

Authors:  Devi Mohan; Kwong Hsia Yap; Daniel Reidpath; Yee Chang Soh; Andrea McGrattan; Blossom C M Stephan; Louise Robinson; Nathorn Chaiyakunapruk; Mario Siervo
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.